Latest On Shionogi & Co., Ltd (SGIOF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 13:27 EST | News | Shionogi & Co. GAAP EPS of ¥621.31, revenue of ¥426.7B | N/A |  |
| 2023-02-06 11:56 EST | News | Shionogi & Co. reports Q3 results | N/A | |
| 2022-08-01 19:05 EST | News | Shionogi & Co. GAAP EPS of ¥115.13, revenue of ¥71.84B | N/A | |
| 2022-07-20 15:36 EST | News | Shionogi faces setback for COVID pill as Japan delays authorization again | N/A | |
| 2022-02-01 19:28 EST | News | Gilead settles patent dispute with ViiV Healthcare over HIV drug | N/A | |
| 2022-01-31 10:27 EST | News | Shionogi & Co. GAAP EPS of ¥235.43, revenue of ¥219.63B | N/A | |
| 2021-12-20 18:36 EST | News | GSK/Pfizer's Apretude approved as long-acting, injectable HIV PrEP treatment | N/A | |
| 2021-10-21 21:36 EST | News | Shionogi begins phase 2/3 trial of potential COVID-19 vaccine in Japan | N/A | |
| 2021-10-21 21:36 EST | News | Shionogi's oral drug for COVID-19 seen to be safe in phase 1 trial | N/A | |
| 2021-03-30 06:04 EST | Dividend | A dividend of $53 has been announced on May 11, 2020. It will be paid Nov 30, -0001 with an ex-dividend date of Mar 30, 2021. | Neutral | |
| 2021-02-04 09:16 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-02 13:34 EST | Earnings Estimate | An EPS average of $0.60 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-02 00:18 EST | News | Shionogi & Co. reports 9M results | N/A | |
| 2020-11-26 22:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-17 10:17 EST | News | European advisory group backs ViiV's cabotegravir and rilpivirine regimen in HIV | N/A | |
| 2020-10-13 14:40 EST | Earnings Estimate | An EPS average of $0.69 is estimated for the quarter ending on December 31, 2020. | Sell | |
| 2020-09-26 15:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-02 06:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 12:19 EST | News | Shionogi & Co. reports Q1 results | N/A | |
| 2020-07-30 18:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-02 10:14 EST | Earnings Estimate | An EPS average of $3.71 is estimated for the 2022 year. | Buy | |
| 2020-05-27 07:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-23 22:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-08 18:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 22:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-30 06:06 EST | Dividend | A dividend of $50 has been announced on May 9, 2019. It will be paid Jan 1, 1970 with an ex-dividend date of Mar 30, 2020. | Neutral | |
| 2020-03-25 22:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 05:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 23:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-23 00:48 EST | Earnings | Earnings have been released on December 31, 2019, with $127.00 earnings per share. | Buy | |
About Shionogi & Co., Ltd (SGIOF):
Shionogi & Co., Ltd. engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment; and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. The company also offers antibody detection kits for COVID-19. Shionogi & Co., Ltd. has collaboration agreements with Hsiri Therapeutics Inc.; Nagasaki University; Roche Group to develop and commercialize Xofluza; and Nagasaki University and The Kitasato Institute to develop antimalarial drugs and vaccines. The company was formerly known as Shionogi Shoten Co., Ltd. and changed its name to Shionogi & Co., Ltd. in 1943. Shionogi & Co., Ltd. was founded in 1878 and is headquartered in Osaka, Japan.
General
- Name Shionogi & Co., Ltd
- Symbol SGIOF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 5,222
- Fiscal Year EndMarch
- Web URLhttp://www.shionogi.com
View More
Valuation
- Trailing PE 16.64
- Forward PE 17.15
- Price/Sales (Trailing 12 Mt.) 6.12
- Price/Book (Most Recent Quarter) 2.18
- Enterprise Value Revenue 0.04
- Enterprise Value EBITDA 0.08
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $3.38
- Next Year EPS Estimate $3.00
- Profit Margin 39%
- Return on Assets 10%
- Return on Equity 15%
- Earnings Per Share $3.30
- Revenue Per Share $0
- Gross Profit 276.59 billion
- Quarterly Earnings Growth -18%
View More
ESG Rating
Highlights
- Market Capitalization 16.87 billion
- PEG Ratio 14289.2
- Book Value Per Share $18.64
View More
Share Statistics
- Shares Outstanding 303.26 million
- Shares Float 305.51 million
- % Held by Insiders 889%
- % Held by Institutions 53.81%
View More
Technicals
- Beta 0.9
- 52 Week High $67.52
- 52 Week Low $39.08
- 50 Day Moving Average 55.1
- 200 Day Moving Average 53.94
View More
Dividends
- Forward Annual Dividend Rate $1.02
- Forward Annual Dividend Yield 1.91%
- Payout Ratio 39%
- Dividend Date 2018-06-21
- ExDividend Date 2020-09-29
- Dividend Per Share $0.8
- Dividend Yield 0%
View More
Shionogi & Co., Ltd (SGIOF) Dividend Calendar:
SGIOF's last dividend payment was made to shareholders on June 21, 2018.
Shionogi & Co., Ltd pays out 39% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Shionogi & Co., Ltd (SGIOF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2020-12-31 | $N/A | $1.09 | $0.67 | 62.69% |
| 2020-09-30 | 2020-12-31 | $N/A | $1.15 | ||
| 2020-06-30 | 2020-09-30 | $N/A | $0.85 | $77.20 | -98.9% |
| 2020-03-31 | 2020-06-30 | $N/A | $0.66 | $112.46 | -99.42% |
| 2019-12-31 | 2020-03-31 | $852.81 million | $0.96 | $105.90 | -99.1% |
| 2019-09-30 | 2019-12-31 | $755.48 million | $1.17 | $76.39 | -98.47% |
| 2019-06-30 | 2019-09-30 | $730.55 million | $0.81 | $101.45 | -99.2% |
| 2019-03-31 | 2019-06-30 | $884.37 million | $0.73 | $93.00 | -99.22% |
| 2018-12-31 | 2019-03-31 | $885.59 million | $1.11 | ||
| 2018-09-30 | 2018-12-31 | $699.4 million | $1.06 | $107.69 | -99.01% |
| 2018-06-30 | 2018-09-30 | $798.27 million | $0.72 | $52.16 | -98.62% |
| 2018-03-31 | 2018-06-30 | $767.79 million | $0.90 | $55.80 | -98.38% |
| 2017-12-31 | 2018-03-31 | $809.46 million | $0.86 | $72.70 | -98.82% |
| 2017-09-30 | 2017-12-31 | $861.52 million | $0.81 | $50.30 | -98.4% |
| 2017-06-30 | 2017-09-30 | $667.58 million | $0.94 | $45.90 | -97.95% |
| 2017-03-31 | 2017-06-30 | $82.36 billion | $0.44 | $65.30 | -99.33% |
| 2016-12-31 | 2017-03-31 | $101.43 billion | $0.45 | $76.00 | -99.4% |
| 2016-09-30 | 2016-12-31 | $0.95 | $39.90 | -97.61% | |
| 2016-06-30 | 2016-09-30 | $0.56 | $29.90 | -98.14% | |
| 2016-03-31 | 2016-06-30 | $0.37 | $64.30 | -99.43% | |
| 2015-12-31 | 2016-03-31 | $0.67 | |||
| 2015-09-30 | 2015-12-31 | $0.51 | |||
| 2015-06-30 | 2015-09-30 | $0.30 | $16.20 | -98.17% | |
| 2015-03-31 | 2015-06-30 | $0.24 | |||
| 2014-12-31 | 2015-03-31 | $0.45 | $27.65 | -98.38% | |
| 2014-09-30 | 2014-12-31 | $0.41 | $23.20 | -98.22% | |
| 2014-06-30 | 2014-09-30 | -$0.03 | |||
| 2014-03-31 | 2014-06-30 | $0.30 | $22.40 | -98.68% | |
| 2013-12-31 | 2014-03-31 | $0.13 | $0.42 | -68.26% | |
| 2013-09-30 | 2013-12-31 | $0.45 | |||
| 2013-06-30 | 2013-09-30 | $0.32 | |||
| 2013-03-31 | 2013-06-30 | $0.33 | |||
| 2012-12-31 | 2013-03-31 | $1.22 | |||
| 2012-09-30 | 2012-12-31 | $0.47 | |||
| 2012-06-30 | 2012-09-30 | $0.30 | |||
| 2012-03-31 | 2012-06-30 | $0.26 | |||
| 2011-12-31 | 2012-03-31 | $0.31 | |||
| 2011-09-30 | 2011-12-31 | $0.40 | |||
| 2011-06-30 | 2011-09-30 | $0.17 | |||
| 2011-03-31 | 2011-06-30 | $0.14 | |||
| 2010-12-31 | 2011-03-31 | $0.23 | |||
| 2010-09-30 | 2010-12-31 | $0.25 | |||
| 2010-06-30 | 2010-06-30 | $0.16 | |||
| 2010-03-31 | 2010-03-31 | $0.43 | |||
| 2009-12-31 | 2009-12-31 | $0.46 | |||
| 2009-09-30 | 2009-09-30 | $0.22 | |||
| 2009-06-30 | 2009-06-30 | $0.14 |
Shionogi & Co., Ltd (SGIOF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | 479.36 million |
| Selling General Administrative | N/A | N/A | N/A | N/A | 354.01 million |
| Gross Profit | N/A | N/A | N/A | N/A | 732.25 million |
| Ebit | N/A | N/A | N/A | N/A | 378.25 million |
| Operating Income | N/A | N/A | N/A | N/A | 378.25 million |
| Income Tax Expense | 12.95 billion | 9.28 billion | 8.52 billion | 8.7 billion | 118.16 million |
| Total Revenue | N/A | N/A | N/A | N/A | 852.81 million |
| Cost of Revenue | N/A | N/A | N/A | N/A | 120.56 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 101.11 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 361.2 million |
| Net Income Applicable to Common Shares | 36.69 billion | 29.17 billion | 21.54 billion | 30.45 billion | 361.13 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | -460 million | -4.1 billion | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | 5.77 billion | -34.03 billion | N/A | N/A | N/A |
| Net Borrowings | -1.8 billion | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Operating Activities | -960 million | -4.32 billion | N/A | N/A | N/A |
| Change in Cash | N/A | N/A | N/A | N/A | N/A |
| Total Cash from Operating Activities | 32.69 billion | 14.29 billion | N/A | N/A | N/A |
| Depreciation | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Investing Activities | 405 million | 121 million | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | 17 billion | -2.48 billion | N/A | N/A | N/A |
| Change to Net Income | 14.72 billion | -9.96 billion | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | 699.3 million |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | 6.35 billion |
| Other Current Liabilities | 58.75 billion | 59.25 billion | N/A | N/A | 411.12 million |
| Total Assets | N/A | N/A | N/A | N/A | 7.05 billion |
| Common Stock | 21.28 billion | 21.28 billion | 21.28 billion | 21.28 billion | 195.89 million |
| Other Current Assets | 24.7 billion | 17.86 billion | N/A | N/A | 318.19 million |
| Retained Earnings | 728.68 billion | 707.72 billion | 682.55 billion | 729.2 billion | 6.43 billion |
| Other Liabilities | 18.96 billion | 17.94 billion | 20.52 billion | 17.35 billion | 152.85 million |
| Other Assets | 37.61 billion | 12.8 billion | 5.23 billion | 40.67 billion | 369.45 million |
| Cash | N/A | N/A | N/A | N/A | 2.13 billion |
| Total Current Liabilities | 72.4 billion | 72.08 billion | N/A | N/A | 546.46 million |
| Other Stockholder Equity | 96.65 billion | 94.71 billion | 89.75 billion | -10.93 billion | 55.38 million |
| Property, Plant & Equipment | 79.02 billion | 74.9 billion | 74.5 billion | 74.9 billion | 696.02 million |
| Total Current Assets | 544.13 billion | 562.38 billion | N/A | N/A | 4.24 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 1.21 billion |
| Net Tangible Assets | 761.87 billion | 762.27 billion | 693.08 billion | 629.08 billion | 5.82 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | 974.69 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 40.9 billion | 39.07 billion | N/A | N/A | 383.88 million |
| Accounts Payable | 10.33 billion | 9.43 billion | N/A | N/A | 89.68 million |
Shionogi & Co., Ltd (SGIOF) Chart:
Shionogi & Co., Ltd (SGIOF) News:
Below you will find a list of latest news for Shionogi & Co., Ltd (SGIOF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Shionogi & Co., Ltd (SGIOF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Shionogi & Co., Ltd (SGIOF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2013-03-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1281721/000090866213000137/0000908662-13-000137-index.htm |
| 2013-03-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1281721/000090866213000161/0000908662-13-000161-index.htm |
| 2014-02-14 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1281721/000095010314001100/0000950103-14-001100-index.htm |
| 2014-07-14 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1281721/000095010314004866/0000950103-14-004866-index.htm |
| 2015-12-11 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1281721/000095010315009486/0000950103-15-009486-index.htm |
| 2008-10-31 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1281721/000101915508000736/0001019155-08-000736-index.htm |
| 2019-02-15 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1281721/000101915519000042/0001019155-19-000042-index.htm |
| 2008-10-10 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1281721/000110465908063385/0001104659-08-063385-index.htm |
| 2019-03-06 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1281721/000114420419012577/0001144204-19-012577-index.htm |
| 2009-02-20 | RW | Registration Withdrawal Request | https://www.sec.gov/Archives/edgar/data/1281721/000115955409000006/0001159554-09-000006-index.htm |
| 2014-01-29 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1281721/000119312514026422/0001193125-14-026422-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1281721/000119312520034700/0001193125-20-034700-index.htm |
| 2015-08-04 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1281721/000119380515001295/0001193805-15-001295-index.htm |
| 2016-04-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1281721/000119380516003117/0001193805-16-003117-index.htm |
| 2018-06-26 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1281721/000119380518000914/0001193805-18-000914-index.htm |
| 2019-02-20 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1281721/000119380519000228/0001193805-19-000228-index.htm |
| 2019-02-21 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1281721/000119380519000232/0001193805-19-000232-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1281721/000119380519001601/0001193805-19-001601-index.htm |